NA
INSM icon

NewEdge Advisors’s Insmed INSM Stock Holding History

NewEdge Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784K Buy
7,354
+1,339
+22% +$162K ﹤0.01% 1824
2026
Q1 		$984K Buy
6,015
+3,433
+133% +$528K ﹤0.01% 1514
2025
Q4 		$449K Sell
2,582
-557
-18% -$102K ﹤0.01% 2053
2025
Q3 		$452K Buy
+3,139
New +$385K ﹤0.01% 1890

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

NewEdge Advisors's INSM Position: Q2 2026 in Review

NewEdge Advisors increased its Insmed (INSM) stake by 22% in Q2 2026, buying an estimated $162K and bringing the position to 7,354 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

NewEdge Advisors first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $984K in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • NewEdge Advisors held 7,354 shares of Insmed worth $784K as of Q2 2026.
  • NewEdge Advisors bought 1,339 Insmed shares in Q2 2026, an estimated $162K.
  • Insmed made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1824 holding.
  • NewEdge Advisors first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • NewEdge Advisors's Insmed position peaked at $984K in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.